Key result
Surgical delay in geriatric hip fracture patients on DAPT was associated with increased 30-day mortality and major complications, but not transfusion needs.
Why the study?
To determine how timing of surgery affects transfusion, major complications, and mortality in patients sustaining a geriatric hip fracture while on DAPT.
Does surgical delay improve outcomes in geriatric hip fracture patients on dual antiplatelet therapy?
Cohort (n=122)
No
Does surgical delay improve outcomes in geriatric hip fracture patients on dual antiplatelet therapy?
Delaying hip fracture surgery in geriatric patients on DAPT does not reduce transfusion requirements but is associated with higher mortality and major complications.
Answers are grounded in this paper and cite their sources.
Cautions against routine delay in DAPT patients; leaves open optimal timing pending randomized trials.
OBJECTIVE: To determine how timing of surgery affects transfusion, major complications, and mortality in patients who sustain a geriatric hip fracture while taking dual antiplatelet therapy (DAPT; typically aspirin and clopidogrel). DESIGN: Retrospective cohort study. SETTING: University-affiliated Level 1 Trauma Center. PATIENTS: Patients 65 years of age or older on DAPT with a geriatric hip fracture were investigated at a single institution between 2002 and 2017. Demographic and perioperative data were collected from patient records, institutional databases, and national hip fracture registry. INTERVENTION: Fixation or arthroplasty. MAIN OUTCOME MEASUREMENT: Transfusion, major complications, and 30-day mortality. RESULTS: Of the 6724 patients sustaining a geriatric hip fracture, 122 patients were taking DAPT on admission. Timing of surgery did not influence transfused units (incidence rate ratio 1.00, 95% confidence interval: 0.87-1.15, P = 0.968) but did affect major complications (time modeled as quadratic term; odds ratios ranging from 0.20 to 7.91, ptime = 0.001, ptime*time<0.001) and 30-day mortality (odds ratio 1.32, 95% confidence interval: 1.03-1.68, P = 0.030). CONCLUSION: Surgical delay does not change the need for transfusion of hip fracture patients on DAPT, but it is associated with increased probabilities of major complications and 30-day mortality. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
No takes yet. Share an insight, caveat, or question.
Tarrant et al. (2020) conducted a cohort in Geriatric hip fracture (n=122). Surgical delay was evaluated on 30-day mortality (OR 1.32, 95% CI 1.03-1.68, p=0.030). Surgical delay in geriatric hip fracture patients on DAPT was associated with increased 30-day mortality and major complications, but not transfusion needs.
Synapse has enriched 10 related papers. Consider them for comparative context: